إسرائيل - العبرية - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - salmeterol as xinafoate 50 mcg; fluticasone propionate 250 mcg - salmeterol and other drugs for obstructive airway diseases

إسرائيل - العبرية - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - salmeterol as xinafoate 50 mcg; fluticasone propionate 500 mcg - salmeterol and other drugs for obstructive airway diseases

إسرائيل - العبرية - Ministry of Health

glaxo smith kline (israel) ltd - salmeterol as xinafoate - תרחיף לשאיפה - salmeterol as xinafoate 25 mcg/actuation - salmeterol

إسرائيل - العبرية - Ministry of Health

bayer israel ltd - testosterone enantate - תמיסה שומנית להזרקה - testosterone enantate 250 mg/ml - testosterone - testosterone - testosterone replacement therapy in male hypogonadism, in cases where testosterone deficiency has been confirmed on the basis of clinical and lboratory evidence.inducing puberty in boys with delayed puberty (pubertas tarda).

إسرائيل - العبرية - Ministry of Health

glaxo smith kline (israel) ltd - salmeterol as xinafoate - אבקה לשאיפה - salmeterol as xinafoate 50 mcg - salmeterol - salmeterol - regular symptomatic add-on treatment of reversible airways obstruction in patients with asthma, including those with nocturnal asthma, who are inadequately controlled on inhaled corticosteroids in accordance with current treatment guidelines. treatment of chronic obstructive pulmonary disease (copd). prevention of exercise-induced asthma.

إسرائيل - العبرية - Ministry of Health

tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 15 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi

إسرائيل - العبرية - Ministry of Health

tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 30 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi

إسرائيل - العبرية - Ministry of Health

tzamal bio-pharma ltd - pioglitazone as hydrochloride - טבליה - pioglitazone as hydrochloride 45 mg - pioglitazone - pioglitazone - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients wi

إسرائيل - العبرية - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

إسرائيل - العبرية - Ministry of Health

intervet ( israel) ltd - flunixin as meglumine - תמיסה להזרקה - flunixin as meglumine 50 mg/ml